期刊文献+

血管紧张素Ⅱ受体拮抗剂在心血管疾病的临床应用 被引量:5

Clinical Application of Angiotensin Ⅱ Receptor Antagonists in Cardiovascular Diseases
下载PDF
导出
摘要 临床观察发现 :血管紧张素 (Ang )对心脏产生毒副作用 ,Ang 是肾素 -血管紧张素系统 (RAS)中的关键因子 ,RAS是一个酶促连锁反应系统 ,在调节血压、维持体液平衡中起到关键作用。多项临床试验表明 Ang 受体拮抗剂可用于治疗高血压、充血性心力衰竭、心肌肥厚及急性心肌梗塞。其降压效果与血管紧张素转换酶 -抑制剂(ACE- I)、β-受体阻断剂、钙拮抗剂、利尿剂疗效相当 ;但对于充血性心力衰竭的治疗 ,除患者对其耐受性好外 ,目前尚无证据表明其疗效优于 ACE- Clinical observations showed that angiotensin Ⅱ (AngⅡ) has deleterious effects on the heart and it also is the key factor of rennin-angiotensin system(RAS).RAS is an enzymatic cascade,which adjust blood pressure,keep the balance of fluid.A lot of studies have demonstrated that Ang Ⅱ receptor antagonists can be used for the treatment of patients with hypertension,congestive heart failure,ventricular hypertrophy and acute myocardial infarction.Ang Ⅱ receptor antagonists is as effective as ACE in hibitors,β blockers,calcium antagonists and diuretics.No evidence shows that Ang Ⅱ antagonists are superior to ACE I inhibitors except their excellent tolerability profile in patiants with congestive heart failure.
机构地区 天津市第三医院
出处 《华夏医学》 2001年第6期981-984,共4页 Acta Medicinae Sinica
关键词 血管紧张素Ⅱ受体拮抗剂 心血管疾病 血管紧张素Ⅱ 临床应用 angiotensin Ⅱ receptor antagonists cardiovascular diseases
  • 相关文献

参考文献24

  • 1[1]Gavras H,Brown JJ,Lever AF,et al.Acute renal failure,tubular necrosis and myocardial infraction induced in the rabbit by intravenous angiotensin Ⅱ[J].Lancet,1971,2:19-22.
  • 2[2]Brunner HR,Laragh JR,Baer L,et al.Essential hepertension:renin and aldosterone,heart attactk and stroke[J].N Engl J Med,1972,286:441-449.
  • 3[3]Messerli FH,Weber MA,Brunner HR.Angiotension Ⅱ receptor inhibitior[J].Arch Intern Med,1996,156:1957-1965.
  • 4[4]Urata H,Strobel F,Ganten D.Widespread tissue distribution of human chymase[J].J Hypertens,1994,12:17-22.
  • 5[5]Weber MA,Byyny RL,Partt JH,et al.Blood pressure effects of the Angiotension Ⅱ receptor blocker,losartan[J].Arch Inter Med,1995,15:405-411.
  • 6[6]Oparil S,Dyke S,Harris F,et al.The efficacy and safey of valsartan compared with placeebo in the treatment of essential hypertension[J].Clin Ther,1996,18:797-810.
  • 7[7]Pool JL,Guthrie RM,Littlejohn TW,et al.Dose-related antihypertensive effects of irbesartan in patients with mide-to-moderate hypertension[J].AM J Hypertens,1998,11:462-470.
  • 8[8]Oparil S,Bar E,Elkins M,et al.Efficacy,tolerability,and effects on quality of life of losartan,alone or with hydrochlorothiazide,in patients with essential hypertension[J].Clin Ther,1996,18:608-625.
  • 9徐成斌.血管紧张素Ⅱ受体拮抗剂的临床应用[J].中华内科杂志,1999,38(5):349-352. 被引量:37
  • 10[10]Tikkanen I,Omvik P,Jense HA,et al.Comparison of angiotensin Ⅱ antagonist losartan with the angiotension converting enzyme inhibitor enalapril in patients with essential hypertension[J].J Hypertens,1995,13:1343-1351.

二级参考文献7

  • 1孙玲玲 徐成斌.今日高血压(第1版)[M].北京:中国医药科技出版社,2000.645-646.
  • 2Chan P,J Clin Pharmacol,1997年,37卷,253页
  • 3Chan J C,J Hum Hypertens,1995年,9卷,765页
  • 4Huang W,Circulation Res,1998年,82卷,879页
  • 5Gallagher A M,Hypertension,1998年,32卷,84页
  • 6Zhuo J L,Circulation,1997年,96卷,174页
  • 7Kerins D M,J Clin Invest,1995年,96卷,2515页

共引文献89

同被引文献44

引证文献5

二级引证文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部